Dentsply Sirona price target lowered to $20 from $24 at Barrington

Barrington analyst Michael Petusky lowered the firm’s price target on Dentsply Sirona (XRAY) to $20 from $24 and keeps an Outperform rating on the shares post the Q4 report. The impact of the Byte aligner business shutdown and customer refunds accounted for over half of the quarter’s revenue decline, the analyst tells investors in a research note. The firm says that while the shares are “already trading with very high levels of skepticism,” it has “minimal conviction” in its Outperform rating following the “truly awful” Q4 report.